CTKB — Cytek Biosciences, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1831915 ·
Last close
$3.97
Market Cap
$512.70M
52W High
$4.99
52W Low
$3.31
ADV30
872,083
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 44,135,000 | 21,254,000 | -18,463,000 | -18,866,000 | 449,113,000 | 65,665,000 | 121,469,000 |
| Dec 2025 | 62,141,000 | 32,885,000 | -5,594,000 | -44,076,000 | 461,542,000 | 90,853,000 | 119,803,000 |
| Sep 2025 | 52,293,000 | 27,551,000 | -9,192,000 | -5,478,000 | 494,919,000 | 93,281,000 | 116,348,000 |
| Jun 2025 | 45,602,000 | 23,867,000 | -10,624,000 | -5,583,000 | 493,320,000 | 75,470,000 | 115,763,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,686,000
Investing CF
$10,118,000
Financing CF
$-13,433,000
CapEx
$-4,190,000
Dividends Paid
—
Buybacks
$-15,074,000
EPS Diluted TTM
$-0.51
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-101,738,000
Inventory
$48,428,000
Receivables
$72,127,000
ST Investments
$170,676,000
EBIT TTM
$-29,367,000
Pretax Income TTM
$-29,841,000
Interest Exp TTM
$474,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$204,171,008
EBITDA
$-36,303,000
Free Cash Flow
$6,412,875
Enterprise Value
$283,118,784
Total Cash
$262,224,992
Total Debt
$27,482,000
Shares Out
129,142,587
Trailing EPS
$-0.58
Book Value
$2.54
ROE
-20.9%
ROA
-5.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 201,493,000 | -40,384,000 | -66,539,000 | 461,542,000 | 119,803,000 | — | -4,686,000 |
| Dec 2024 | 200,453,000 | -20,523,000 | -6,020,000 | 499,500,000 | 103,763,000 | — | 25,379,000 |
| Dec 2023 | 193,015,000 | -27,845,000 | -12,148,000 | 494,457,000 | 101,393,000 | — | 5,281,000 |
| Dec 2022 | 164,036,000 | -1,804,000 | 2,576,000 | 519,476,000 | 93,930,000 | — | -12,231,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.19
News headlines (Yahoo Finance, 1h cache)
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
2026-05-20 20:51 · Yahoo
Cytek (CTKB) Q1 2026 Earnings Call Transcript
2026-05-08 14:32 · Yahoo
Cytek Biosciences, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates
2026-05-07 23:05 · Yahoo
Cytek Biosciences Q1 Earnings Call Highlights
2026-05-07 21:39 · Yahoo
Cytek Biosciences Reports First Quarter 2026 Financial Results
2026-05-07 20:05 · Yahoo
AbCellera Biologics Among 3 Promising Penny Stocks
2026-05-01 12:05 · Yahoo
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-23 20:05 · Yahoo
Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates
2026-04-14 05:29 · Yahoo
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist
2026-03-25 12:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.